Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
CSL-311 by CSL for Allergic Asthma: Likelihood of Approval
CSL-311 is under clinical development by CSL and currently in Phase I for Allergic Asthma. According to GlobalData, Phase I...